NASDAQ:NEUP | Cash Flow Statement | Neuphoria Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2023-06-30 to 2026-03-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-03-31-$505,063.00
2025-12-31$1.86M
2025-09-30-$9.91M-$3.79M$3.25M
2025-06-30-$8.88M-$3.59M$704,675.00
2025-03-31$11.26M
2024-12-31-$1.94M
2024-09-30-$804,787.00-$4.43M-$227,338.00
2024-06-30-$2.69M-$3.01M$7.12M
2024-03-31-$2.78M
2023-12-31-$4.55M
2023-09-30-$5.47M-$4.43M$612,538.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-06-30-$369,632.00$77,229.00$1.53M
2024-06-30-$15.49M-$14.68M$15.11M
2023-06-30-$21.38M-$14.64M$3.86M